EMEA-001865-PIP02-16

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Omega-3-carboxylic acids

Decision numberP/0377/2017
PIP numberEMEA-001865-PIP02-16
Pharmaceutical form(s)Capsule, soft; Oral age-appropriate formulation
Condition(s)/indication(s)

Treatment of dyslipidemia

Route(s) of administrationOral use
PIP applicant

AstraZeneca AB
Tel. +46 855327591
E-mail: paediatrics@astrazeneca.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision